B110 NOVEL THERAPIES AND TARGETS IN FIBROSIS: Pharmacological Profile And Efficacy Of Glpg1690, A Novel Autotaxin Inhibitor For The treatment Of Idiopathic Pulmonary Fibrosis
Van Der Aar, E M, Heckmann, B, Blanque, R, Desroy, N, Dupont, S, Cottereaux, C, Monjardet, A, Wakselman, E, Dirven, D, Christophe, T, Hrvacic, B, Ralic, J, Marsais, F, Brys, R
Published in American journal of respiratory and critical care medicine (01.01.2016)
Get full text
Published in American journal of respiratory and critical care medicine (01.01.2016)
Journal Article